Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents – minimum inhibitory concentration versus time-kill curves-Reference-Cited by-同舟云学术

Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents – minimum inhibitory concentration versus time-kill curves

Published:2007-06 Issue:6 Volume:2 Page:849-860
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Schmidt Stephan,Schuck Edgar,Kumar Vipul,Burkhardt Olaf,Derendorf Hartmut

Publisher

Informa Healthcare

Subject

Drug Discovery

Link

http://www.tandfonline.com/doi/pdf/10.1517/17460441.2.6.849

Reference100 articles.

1. Pharmacokinetic/Pharmacodynamic Studies in Drug Product Development

2. Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris;CPT: Pharmacometrics & Systems Pharmacology;2023-03-13

2. The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review;Antibiotics;2023-03-01

3. Pharmacokinetic/Pharmacodynamic Modeling and Application in Antibacterial and Antifungal Pharmacotherapy: A Narrative Review;Antibiotics;2022-07-22

4. Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences;Antibiotics;2022-07-08

5. Pharmacokinetic and Pharmacodynamic Evaluation of Gemifloxacin Chitosan Nanoparticles As an Antibacterial Ocular Dosage Form;Journal of Pharmaceutical Sciences;2021-12